BioCentury
ARTICLE | Company News

BMS partners with Yale Cancer Center as part of immuno-oncology network

March 2, 2018 9:01 PM UTC

Bristol-Myers Squibb Co. (NYSE:BMY) partnered with the Yale Cancer Center at Yale School of Medicine to perform translational immuno-oncology research as part of BMS’s International Immuno-Oncology Network (II-ON)...